Endoscopic calcaneoplasty: 5-year results.

Area of Science:

• Orthopedic Surgery
• Foot and Ankle Surgery
• Minimally Invasive Procedures

Background:

• Haglund's disease involves a bony enlargement on the heel bone, causing pain and inflammation of the retrocalcaneal bursa.
• Retrocalcaneal bursitis is inflammation of the bursa located between the heel bone and the Achilles tendon.
• Conservative treatments are often insufficient for severe cases, necessitating surgical intervention.

Purpose of the Study:

• To evaluate the efficacy of endoscopic calcaneoplasty for treating Haglund's disease and retrocalcaneal bursitis.
• To assess patient outcomes, including functional scores and satisfaction, following the procedure.

Main Methods:

• A prospective study included 30 feet from 28 patients undergoing endoscopic calcaneoplasty.
• The procedure involved removing the inflamed bursa and resecting bone to eliminate Achilles tendon friction.
• Patients were allowed full weight-bearing at two weeks post-surgery, with outcomes measured by AOFAS scores and patient satisfaction.

Main Results:

• The average follow-up period was 58.4 months.
• American Orthopedic Foot and Ankle Society (AOFAS) scores significantly improved from 52.6 to 98.6 post-surgery (p<0.005).
• All patients reported high satisfaction with the surgical outcomes.

Conclusions:

• Endoscopic calcaneoplasty is a safe and effective surgical technique for Haglund's disease and retrocalcaneal bursitis.
• The procedure leads to significant functional improvement and high patient satisfaction.
• This minimally invasive approach offers a viable treatment option for these foot conditions.